FDA might mandate drug training

Perhaps triplicate prescriptions are not enough of a safety measure when it comes to powerful narcotics. At least, that's what the FDA might be thinking. The agency is considering mandatory training for clinicians who prescribe certain narcotic medications, including methadone, fentanyl and some versions of oxycodone.

It's a move that would be controversial and one that the FDA cannot make in a vacuum, according to Bob Rappaport, the agency's director for the division of Anesthesia, Analgesia and Rheumatology Products, as states usually have jurisdiction over regulatory and education issues when it comes to physicians.

As it stands, a state medical license and a simple registration with the Drug Enforcement Administration are all that are necessary for a physician to prescribe narcotics. At present, states like California that require additional training are the exception rather than the norm.  

- read the full story in the New York Times

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.